agilon health, inc. (AGL) Operating Margin
- Operating margin · 12 months: Value -5.23%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -5.23% | Operating income / revenue. Period ending 2026-06-30. $-309.33M ÷ $5.92B × 100 ≈ -5.23% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -309.33M USD | Operating Income (Loss) |
| Revenue | 5.92B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-309.33M | $5.92B | (m) | (m) | (m) | -5.23% |
| 2026-03-31 | $-437.13M | $5.82B | (m) | (m) | (m) | -7.51% |
| 2025-12-31 | $-463.24M | $5.93B | (m) | (m) | (m) | -7.81% |
| 2025-09-30 | $-377.51M | $5.89B | (m) | (m) | (m) | -6.41% |
| 2025-06-30 | $-379.75M | $5.90B | (m) | (m) | (m) | -6.44% |
| 2025-03-31 | $-307.06M | $5.99B | (m) | (m) | (m) | -5.13% |
| 2024-12-31 | $-292.13M | $6.06B | (m) | (m) | (m) | -4.82% |
| 2024-09-30 | $-348.33M | $5.59B | (m) | (m) | (m) | -6.23% |
| 2024-06-30 | $-254.12M | $5.28B | (m) | (m) | (m) | -4.81% |
| 2024-03-31 | $-239.73M | $4.87B | (m) | (m) | (m) | -4.93% |
| 2023-12-31 | $-232.13M | $4.32B | (m) | (m) | (m) | -5.38% |
| 2023-09-30 | $-141.65M | $4.19B | (m) | (m) | (m) | -3.38% |
| 2023-06-30 | $-122.20M | $3.67B | (m) | (m) | (m) | -3.33% |
| 2023-03-31 | $-113.43M | $3.19B | (m) | (m) | (m) | -3.55% |
| 2022-12-31 | $-120.43M | $2.71B | (m) | (m) | (m) | -4.45% |
| 2022-09-30 | $-99.19M | $2.48B | (m) | (m) | (m) | -4.00% |
| 2022-06-30 | $-105.27M | $2.25B | (m) | (m) | (m) | -4.69% |
| 2022-03-31 | $-382.58M | $2.07B | (m) | (m) | (m) | -18.45% |
| 2021-12-31 | $-393.95M | $1.83B | (m) | (m) | (m) | -21.49% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-56.67M | $1.22B | (m) | (m) | (m) | -4.65% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-106.57M | $794.41M | (m) | (m) | (m) | -13.42% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |